Literature DB >> 17877674

A randomised comparison of patient satisfaction with vaginal and sublingual misoprostol for induction of labour at term.

A H Nassar1, J Awwad, A M Khalil, A Abu-Musa, G Mehio, I M Usta.   

Abstract

OBJECTIVE: To compare patient satisfaction with two routes of misoprostol for term labour induction.
DESIGN: Prospective randomised trial.
SETTING: Tertiary care hospital. POPULATION: A total of 170 women admitted at > or = 37 weeks of gestation for induction of labour.
METHODS: Women were randomised to receive 50 micrograms of either sublingual or vaginal misoprostol. MAIN OUTCOME MEASURES: Patient satisfaction with the route of administration.
RESULTS: Despite a similar proportion reporting the labour induction as more painful than expected in both groups, a significantly lower proportion mentioned that the pelvic examinations were very painful in the sublingual group (19.7 versus 36.1%, relative risk [RR] 0.5, 95% CI 0.3-0.9). Request for analgesia was similar in both groups. More women in the sublingual group thought that the labour experience was better than expected (RR 2.0, 95% CI 1.2-3.3), had a positive attitude towards induction in subsequent pregnancies (RR 1.6, 95% CI 1.1-2.3) and preferred the same route in subsequent pregnancies (RR 3.1, 95% CI 2.2-4.5). Mean number of misoprostol doses, oxytocin augmentation, tachysystole and hyperstimulation, induction to vaginal delivery interval, vaginal delivery after a single dose, vaginal birth within 12 and 24 hours, and caesarean delivery rates were similar in both groups.
CONCLUSION: Sublingual misoprostol (50 micrograms) is associated with a significantly higher patient satisfaction rate compared with a similar dose of vaginal misoprostol. Sublingual administration offers additional choice to women, in particular those wishing to avoid vaginal administration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17877674     DOI: 10.1111/j.1471-0528.2007.01492.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  4 in total

1.  A comparison of vaginal versus buccal misoprostol for cervical ripening in women for labor induction at term (the IMPROVE trial): a triple-masked randomized controlled trial.

Authors:  David M Haas; Joanne Daggy; Kathleen M Flannery; Meredith L Dorr; Carrie Bonsack; Surya S Bhamidipalli; Rebecca C Pierson; Anthony Lathrop; Rachel Towns; Nicole Ngo; Annette Head; Sarah Morgan; Sara K Quinney
Journal:  Am J Obstet Gynecol       Date:  2019-05-07       Impact factor: 8.661

2.  Sublingual versus Vaginal Misoprostol for the Induction of Labor at Term: A Randomized, Triple-Blind, Placebo-Controlled Clinical Trial.

Authors:  Bahia Namavar Jahromi; Foroogh Poorgholam; Gholamhossein Yousefi; Leila Salarian
Journal:  Iran J Med Sci       Date:  2016-03

3.  Misoprostol administered sublingually at a dose of 12.5 μg versus vaginally at a dose of 25 μg for the induction of full-term labor: a randomized controlled trial.

Authors:  Daniele S M B Gattás; Melania M R de Amorim; Francisco E L Feitosa; José R da Silva-Junior; Lívia C G Ribeiro; Gustavo F A Souza; Alex S R Souza
Journal:  Reprod Health       Date:  2020-04-10       Impact factor: 3.223

Review 4.  Buccal or sublingual misoprostol for cervical ripening and induction of labour.

Authors:  G Muzonzini; G J Hofmeyr
Journal:  Cochrane Database Syst Rev       Date:  2004-10-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.